共 385 条
[1]
Kuderer NM(2006)Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients Cancer 106 2258-2266
[2]
Dale DC(2003)Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices J Clin Oncol 21 4524-4531
[3]
Crawford J(2004)Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study J Clin Oncol 22 4302-4311
[4]
Cosler LE(2006)Chemotherapy dose intensity and quality cancer care Oncology (Williston Park) 20 16-25
[5]
Lyman GH(2013)The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials Ann Oncol 24 2475-2484
[6]
Lyman GH(2008)Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice J Natl Compr Canc Netw 6 109-118
[7]
Dale DC(2005)First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study J Clin Oncol 23 1178-1184
[8]
Crawford J(2014)Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study Cancer Med 3 434-444
[9]
Lyman GH(1989)Hematopoietic growth factors. Biology and clinical applications N Engl J Med 321 1449-1459
[10]
Dale DC(2006)2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline J Clin Oncol 24 3187-3205